학술논문
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Document Type
Article
Author
Highland, Kristin B ; Distler, Oliver ; Kuwana, Masataka; Allanore, Yannick; Assassi, Shervin; Azuma, Arata; Bourdin, Arnaud; Denton, Christopher P; Distler, Jörg H W; Hoffmann-Vold, Anna Maria; Khanna, Dinesh; Mayes, Maureen D; Raghu, Ganesh; Vonk, Madelon C; Gahlemann, Martina; Clerisme-Beaty, Emmanuelle; Girard, Mannaig; Stowasser, Susanne; Zoz, Donald; Maher, Toby M
Source
In The Lancet Respiratory Medicine January 2021 9(1):96-106
Subject
Language
ISSN
2213-2600